33
Growth Score in past quarter
pts
Heat Score 33 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4046804
Axordia Limited researches human stem cells in order to develop therapeutic treatments for debilitating diseases, such as heart disease,
- Harry Moore: Founder
- Peter Andrews: Founder
About the Company
Axordia Limited researches human stem cells in order to develop therapeutic treatments for debilitating diseases, such as heart disease, liver failure, Parkinson's and multiple sclerosis. The company was formerly known as Cellbiosys Limited and changed its name to Axordia Limited in May, 2001. The company was incorporated in 1999 and is based
in Sheffield, United Kingdom. As of December 22, 2008, Axordia Limited operates as a subsidiary of Intercytex Group Plc.
